Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare
NCI - National Cancer Institute
About This Grant
PROJECT SUMMARY/ABSTRACT Older adult populations have a disproportionate burden of lung cancer, with approximately three-quarters of patients being diagnosed at age 65 and older. Despite poor prognosis of lung cancer, advances in treatment have significantly improved survival in the past three decades. Yet, only around half of older adults with lung cancer received guidelines-concordant treatment. Furthermore, high-quality lung cancer care is not uniformly administered within older adults, and suboptimal treatment and outcomes have been well documented in selected subgroups. Medicare is a public program providing health insurance to older adults. Medicare enrollees receive their healthcare coverage through either traditional Medicare (TM) (i.e. fee-for-service) program or Medicare Advantage (MA) program that is run by private insurers and paid at capitated rates. MA enrollment has increased dramatically since 2005 with more than half of Medicare enrollees now on MA plans. These two Medicare programs have different features. TM beneficiaries are free to choose almost any providers and do not need a specialist referral. By contrast, MA plans reduce costs by limiting access to in-network providers, incentivizing primary care, and reducing utilization of unnecessary health services. MA plans offer extra benefits beyond the coverage provided by TM to address patient’s social needs. Very little is known regarding the impact of MA vs TM on cancer treatment and outcomes. Despite the more rapid growth in MA enrollment among selected subgroups, it remains unknown regarding the performance of MA vs TM in improving cancer care quality for these populations. To fill these important knowledge gaps, we will leverage large databases to create the nationally representative cohorts of lung cancer patients and adults eligible for lung cancer screening to comprehensively evaluate the delivery and quality of lung cancer care among older adults enrolled in MA and TM. Specifically, we will examine the impacts of MA vs TM on lung cancer early detection, treatment, and survival outcomes. Furthermore, we will elucidate the role of MA vs TM in lung cancer care by sociodemographic characteristics of patients. The proposed research will be the first to comprehensively evaluate early detection, treatment, and survival of lung cancer in MA vs TM beneficiaries and the contribution of MA to lung cancer care for selected subgroups. As MA enrollment among older adults has grown rapidly over the past decade, it is imperative to fully understand the impact of MA on cancer care and outcomes. The findings will inform Medicare policy optimizations and help older patients with lung cancer in choosing their health insurance coverage model.
Grant Summary
Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare is a NCI - National Cancer Institute grant providing up to $425K for university, nonprofit, healthcare org. Applications are due 2031-04-30 (open). Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $425K
2031-04-30
- 1Confirm your organization is eligible for Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare from NCI - National Cancer Institute, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NCI - National Cancer Institute before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NCI - National Cancer Institute's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare: Frequently Asked Questions
Who is eligible for the Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare?
Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare is offered by NCI - National Cancer Institute and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare provide?
Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare provides up to $425K per award from NCI - National Cancer Institute. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare deadline?
Applications for Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare are due 2031-04-30 (open). Because deadlines can change, verify the date with the funder, NCI - National Cancer Institute, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare?
To apply for Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NCI - National Cancer Institute.